ArticleBMC cardiovascular disorders2025
Predictive value of the CHA₂DS₂-VASc-HSF score for slow flow during rotational atherectomy in patients with severe coronary artery calcification.
Article in BMC cardiovascular disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Correction: Predictive value of the CHA₂DS₂-VASc-HSF score for slow flow during rotational atherectomy in patients with severe coronary artery calcification.BMC cardiovascular disorders · 2025Article
Corrections and comments
- Erratum issued
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSlow flow is a frequent complication of rotational atherectomy (RA) for severe coronary artery calcification (CAC), yet effective preprocedural risk stratification tools are lacking. The CHA₂DS₂-VASc-HSF score incorporates multiple cardiovascular risk factors and may help predict adverse procedural outcomes.
methodsWe retrospectively analyzed 256 patients with severe CAC undergoing RA. Patients were divided into a slow flow group (thrombolysis in myocardial infarction (TIMI) 0–2) and normal flow group (TIMI 3) based on post-RA angiographic assessment. Clinical, procedural, and angiographic data were compared. Independent predictors were identified using multivariate logistic regression, and receiver operating characteristic analysis assessed the predictive performance of variables.
resultsSlow flow occurred in 18.8% of patients. The slow flow group had significantly higher CHA₂DS₂-VASc-HSF scores, longer lesion lengths, smaller reference vessel diameters, and lower preprocedural systolic blood pressure (SBP). Multivariate analysis identified all four as independent predictors. The CHA₂DS₂-VASc-HSF score alone had moderate predictive value (area under the curve (AUC) = 0.658), while a combined model incorporating the score with lesion length, reference diameter, and SBP achieved the highest accuracy (AUC = 0.893). Slow flow was also associated with a higher in-hospital rate of major adverse cardiovascular events.
conclusionThe CHA₂DS₂-VASc-HSF score is an independent predictor of slow flow during RA and, when combined with anatomical and hemodynamic variables, may enhance risk stratification. These findings support its use in preprocedural planning for patients with severe CAC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.